Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing ...

"We found several cell-type-specific genes and pathways that are dysregulated in both Alzheimer's disease and alcohol, which supports the hypothesis that alcohol use disorder can accelerate ...

Personalised pathways and industry partnerships set students on a journey to future careers Dubai, United Arab Emirates — Nord Anglia Education (NAE) schools in the UAE are launching an exciting array ...

This energy shortage creates toxic proteins, which gradually kill neurons, bringing on the symptoms of Parkinson’s Disease. Why Pathways Matter in Parkinson’s Disease The pathways affected by ...

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

The CDC estimates that six in ten adults in the United States currently live with a chronic disease such as cancer, heart disease, or diabetes. Chronic diseases are among the leading causes of ...

IVs should exclusively impact the outcome via the designated exposure and not through alternative pathways. Figure 1. Overview of current MR analyses and assumptions. IPDGC, International Parkinson’s ...

Mission Statement: Evidence-based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research ...